202 related articles for article (PubMed ID: 25777095)
1. Surgical Treatment of Recurrent Endometrial Cancer: Time for a Paradigm Shift.
Papadia A; Bellati F; Ditto A; Bogani G; Gasparri ML; Di Donato V; Martinelli F; Lorusso D; Benedetti-Panici P; Raspagliesi F
Ann Surg Oncol; 2015 Dec; 22(13):4204-10. PubMed ID: 25777095
[TBL] [Abstract][Full Text] [Related]
2. "The impact of debulking surgery in patients with node-positive epithelial ovarian cancer: Analysis of prognostic factors related to overall survival and progression-free survival after an extended long-term follow-up period".
Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Cuesta-Guardiola T; Peregrin I; Mendizabal E; Lizarraga S; Ortiz-Quintana L
Surg Oncol; 2016 Mar; 25(1):49-59. PubMed ID: 26979641
[TBL] [Abstract][Full Text] [Related]
3. Laparoscopic versus open surgery for endometrial cancer: a minimum 3-year follow-up study.
Ghezzi F; Cromi A; Uccella S; Siesto G; Giudici S; Serati M; Franchi M
Ann Surg Oncol; 2010 Jan; 17(1):271-8. PubMed ID: 19826876
[TBL] [Abstract][Full Text] [Related]
4. Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation.
Fotopoulou C; Zang R; Gultekin M; Cibula D; Ayhan A; Liu D; Richter R; Braicu I; Mahner S; Harter P; Trillsch F; Kumar S; Peiretti M; Dowdy SC; Maggioni A; Trope C; Sehouli J
Ann Surg Oncol; 2013 Apr; 20(4):1348-54. PubMed ID: 23054114
[TBL] [Abstract][Full Text] [Related]
5. Surgical resection of recurrent endometrial carcinoma.
Awtrey CS; Cadungog MG; Leitao MM; Alektiar KM; Aghajanian C; Hummer AJ; Barakat RR; Chi DS
Gynecol Oncol; 2006 Sep; 102(3):480-8. PubMed ID: 16490236
[TBL] [Abstract][Full Text] [Related]
6. Tertiary Cytoreduction for Recurrent Epithelial Ovarian Cancer: a Multicenter Study in Turkey.
Arvas M; Salihoglu Y; Sal V; Gungor T; Sozen H; Kahramanoglu I; Topuz S; Demirkiran F; Iyibozkurt C; Bese T; Ozgu BS; Vatansever D; Tokgozoglu N; Berkman S; Turan H; Bengisu E; Sofiyeva N; Demiral I; Meydanli M
Asian Pac J Cancer Prev; 2016; 17(4):1909-15. PubMed ID: 27221875
[TBL] [Abstract][Full Text] [Related]
7. Pre-operative assessment of muscle mass to predict surgical complications and prognosis in patients with endometrial cancer.
Kuroki LM; Mangano M; Allsworth JE; Menias CO; Massad LS; Powell MA; Mutch DG; Thaker PH
Ann Surg Oncol; 2015 Mar; 22(3):972-9. PubMed ID: 25190123
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome of tertiary surgical cytoreduction in patients with recurrent epithelial ovarian cancer.
Fotopoulou C; Richter R; Braicu IE; Schmidt SC; Neuhaus P; Lichtenegger W; Sehouli J
Ann Surg Oncol; 2011 Jan; 18(1):49-57. PubMed ID: 20697821
[TBL] [Abstract][Full Text] [Related]
9. Perioperative morbidity and mortality in octogenarians with ovarian cancer.
Walters CL; Schneider KE; Whitworth JM; Fauci JM; Smith HJ; Barnes MN; Straughn JM
Int J Gynecol Cancer; 2013 Jul; 23(6):1006-9. PubMed ID: 23714708
[TBL] [Abstract][Full Text] [Related]
10. Analysis of patients with stage IIIC endometrial cancer.
Turan T; Ureyen I; Duzguner I; Ozkaya E; Tasci T; Karalok A; Boran N; Kose MF; Tulunay G
Int J Gynecol Cancer; 2014 Jul; 24(6):1033-41. PubMed ID: 24905617
[TBL] [Abstract][Full Text] [Related]
11. Secondary Cytoreduction in Platinum-Resistant Recurrent Ovarian Cancer: A Single-Institution Experience.
Musella A; Marchetti C; Palaia I; Perniola G; Giorgini M; Lecce F; Vertechy L; Iadarola R; De Felice F; Monti M; Muzii L; Angioli R; Panici PB
Ann Surg Oncol; 2015 Dec; 22(13):4211-6. PubMed ID: 25801357
[TBL] [Abstract][Full Text] [Related]
12. Endometrial carcinoma with extra-abdominal metastasis: improved prognosis following cytoreductive surgery.
Ueda Y; Enomoto T; Miyatake T; Egawa-Takata T; Ugaki H; Yoshino K; Fujita M; Kimura T
Ann Surg Oncol; 2010 Apr; 17(4):1111-7. PubMed ID: 20058191
[TBL] [Abstract][Full Text] [Related]
13. HE4 expression in plasma correlates with surgical outcome and overall survival in patients with first ovarian cancer relapse.
Braicu EI; Chekerov R; Richter R; Pop C; Nassir M; Loefgren H; Stamatian F; Muallem MZ; Hall C; Fotopoulou C; Sehouli J; Pietzner K
Ann Surg Oncol; 2014 Mar; 21(3):955-62. PubMed ID: 24217786
[TBL] [Abstract][Full Text] [Related]
14. Impact of body mass index on surgical outcomes and analysis of disease recurrence for patients with endometrial cancer undergoing robotic-assisted staging.
Menderes G; Azodi M; Clark L; Xu X; Lu L; Ratner E; Schwartz PE; Rutherford TJ; Santin AD; Silasi DA
Int J Gynecol Cancer; 2014 Jul; 24(6):1118-25. PubMed ID: 24927247
[TBL] [Abstract][Full Text] [Related]
15. Optimal cytoreduction, depth of myometrial invasion, and age are independent prognostic factors for survival in women with uterine papillary serous and clear cell carcinomas.
Solmaz U; Mat E; Ekin A; Gezer C; Biler A; Peker N; Ayaz D; Sanci M
Int J Surg; 2016 Aug; 32():71-7. PubMed ID: 27365052
[TBL] [Abstract][Full Text] [Related]
16. Predictors of favorable survival after secondary cytoreductive surgery for recurrent endometrial cancer.
Shikama A; Minaguchi T; Takao W; Hosokawa Y; Nishida K; Tasaka N; Akiyama A; Sakurai M; Ochi H; Satoh T
Int J Clin Oncol; 2019 Oct; 24(10):1256-1263. PubMed ID: 31098693
[TBL] [Abstract][Full Text] [Related]
17. Impact of the lymphadenectomy in high-risk histologic types of endometrial cancer: a matched-pair study.
Coronado PJ; Fasero M; Baquedano L; Martinez-Maestre MA; Casado A; Vidart JA; Herraiz MA
Int J Gynecol Cancer; 2014 May; 24(4):703-12. PubMed ID: 24651627
[TBL] [Abstract][Full Text] [Related]
18. Clear cell and papillary serous endometrial carcinomas: survival in a series of 128 cases.
Scarfone G; Secomandi R; Parazzini F; Viganò R; Mangili G; Frigerio L; Villa A; Tateo S; Ricci E; Bolis G
Arch Gynecol Obstet; 2013 Feb; 287(2):351-6. PubMed ID: 23100038
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome and late side effects in endometrial cancer patients treated with surgery and postoperative radiation therapy.
Herrera FG; Cruz OS; Achtari C; Bourhis J; Ozsahin M
Ann Surg Oncol; 2014 Jul; 21(7):2390-7. PubMed ID: 24604587
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and clinical outcome of patients with recurrent early-stage epithelial ovarian cancer: an Italian multicenter retrospective study.
Gadducci A; Cosio S; Zola P; Sostegni B; Fuso L; Sartori E
Int J Gynecol Cancer; 2013 Mar; 23(3):461-8. PubMed ID: 23370604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
